Compass Therapeutics Inc
For the period ended Mar 31, 2024. Filed May 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 13, 2024
CMPX$0.84+0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets (Unaudited)
| March 31, 2024 (unaudited) | December 31, 2023 (Note 1) | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $23,674 | $24,228 |
| Marketable securities | 132,581 | 128,233 |
| Prepaid expenses and other current assets | 2,356 | 1,420 |
| Total current assets | 158,611 | 153,881 |
| Property and equipment, net | 744 | 898 |
| Operating lease, right-of-use ("ROU") asset | 1,467 | 1,776 |
| Other assets | 320 | 320 |
| Total assets | $161,142 | $156,875 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $854 | $4,090 |
| Accrued expenses | 1,815 | 2,514 |
| Operating lease obligations, current portion | 1,224 | 1,197 |
| Total current liabilities | 3,893 | 7,801 |
| Operating lease obligations, long-term portion | 189 | 536 |
| Total liabilities | 4,082 | 8,337 |
| Commitments and contingencies (Note 7) | ||
| Stockholders' equity: | ||
| Common stock, $0.0001 par value: 300,000 shares authorized; 137,589 and 127,668 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 14 | 13 |
| Additional paid-in-capital | 483,231 | 463,796 |
| Accumulated other comprehensive (loss) income | (90) | 37 |
| Accumulated deficit | (326,095) | (315,308) |
| Total stockholders' equity | 157,060 | 148,538 |
| Total liabilities and stockholders' equity | $161,142 | $156,875 |
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
(In thousands, except per share data)
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.